Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Runda Biotechnology is a prominent Chinese animal health company dedicated to the research, development, and manufacturing of veterinary biologics and pharmaceuticals. The company specializes in high-quality vaccines for poultry and livestock, addressing critical diseases such as avian influenza and swine fever. Operating out of large-scale, GMP-certified facilities in Qingdao, Runda integrates advanced biotechnology with comprehensive technical support services for the agricultural sector. Their portfolio includes a wide range of inactivated and live attenuated vaccines, as well as veterinary drugs and feed additives. Runda is recognized as a key high-tech enterprise in China's animal husbandry industry and serves as a designated manufacturer for national compulsory immunization programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao RunDa Biotechnology.